| 英文名稱： |
Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine |
| 英文別名： |
Lapatinib Base N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-Quinazolinamine;GW2016 LAPATINIB;GW-572016;TYKERB;lapatinib;n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine;4-Quinazolinamine, N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-;Lapatinib(TINIBS);GW572016;Lapatinib ( GSK572016,GW2016,GW-572016);Lapatinib base;4-{[3-chloro-4-(3-fluoro-benzyloxy)-phenyl]amino}-6-(5-{[(2-methanesulphonyl-ethyl)amino]methyl}-furan-2-yl)quinazoline;4-{[3-chloro-4-(3-fluoro-benzyloxy)-phenyl]amino}-6-(5-{[(2-methansulfonyl-ethyl)amino]methyl}-furan-2-yl)quinazoline;N-{3-Chloro-4-[(3-fluorobenzyl) oxy]phenyl}-6-[5-({[2-(methanesulphonyl) ethyl]amino}methyl)-2-furyl]-4-quinazolinamine;N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethy;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine |
| 中文別名： |
拉帕替尼;N-[3-氯-4-[(3-氟苯基)甲氧基]苯基]-6-[5-[(2-甲磺酰乙基氨基)甲基]-2-呋喃基]喹唑啉-4-胺;拉帕替尼堿;二甲苯磺酸拉帕替尼中間體;GW 572016LAPATINIB拉帕替尼;Lapatinib 抑制劑;N-[3-氯-4-[(3-氟苯基)甲氧基]苯;甲苯磺酸拉帕替尼雜質(zhì);拉帕替尼-1;拉帕替尼及其中間體;拉帕替尼堿基;拉帕替尼雜質(zhì);拉帕替尼雜質(zhì)（Lapatinib）對照品;拉帕替尼雜質(zhì)Lapatinib;戊柔比星;枸櫞酸他莫昔芬;枸櫞酸他莫昔芬,他莫昔芬檸檬酸鹽 |
| CAS No.： |
231277-92-2 |
| 分子式： |
C29H26CLFN4O4S |
| 分子量： |
581.06 |
| 純度： |
98% |
.png)
滬公網(wǎng)安備 31011502020044號
危險化學(xué)品經(jīng)營許可證
水濤